118 related articles for article (PubMed ID: 16178435)
1. [Emphasize the role of bioactive small molecules in the homeostasis regulation of cardiovascular system].
Tang CS; Pu D
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):440-2. PubMed ID: 16178435
[TBL] [Abstract][Full Text] [Related]
2. Genetic and genomic approaches to identify and study the targets of bioactive small molecules.
Zheng XS; Chan TF; Zhou HH
Chem Biol; 2004 May; 11(5):609-18. PubMed ID: 15157872
[TBL] [Abstract][Full Text] [Related]
3. Bioactive peptides, networks and systems biology.
Boonen K; Creemers JW; Schoofs L
Bioessays; 2009 Mar; 31(3):300-14. PubMed ID: 19260025
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular endothelins: essential regulators of cardiovascular homeostasis.
Brunner F; Brás-Silva C; Cerdeira AS; Leite-Moreira AF
Pharmacol Ther; 2006 Aug; 111(2):508-31. PubMed ID: 16457892
[TBL] [Abstract][Full Text] [Related]
5. Implication of microRNAs in the cardiovascular system.
Scalbert E; Bril A
Curr Opin Pharmacol; 2008 Apr; 8(2):181-8. PubMed ID: 18243792
[TBL] [Abstract][Full Text] [Related]
6. Cross-link breakers as a new therapeutic approach to cardiovascular disease.
Susic D
Biochem Soc Trans; 2007 Nov; 35(Pt 5):853-6. PubMed ID: 17956231
[TBL] [Abstract][Full Text] [Related]
7. [Vasoactive polypeptides and cardiovascular endocrine diseases].
Zeng ZP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):443-5. PubMed ID: 16178436
[TBL] [Abstract][Full Text] [Related]
8. A chemogenomic approach to drug discovery: focus on cardiovascular diseases.
Cases M; Mestres J
Drug Discov Today; 2009 May; 14(9-10):479-85. PubMed ID: 19429507
[TBL] [Abstract][Full Text] [Related]
9. Androgens and morphologic remodeling at penile and cardiovascular levels: a common piece in complicated puzzles?
Mirone V; Imbimbo C; Fusco F; Verze P; Creta M; Tajana G
Eur Urol; 2009 Aug; 56(2):309-16. PubMed ID: 19147269
[TBL] [Abstract][Full Text] [Related]
10. [Advances in cardiovascular system endocrine].
Tang CS; Qi YF
Sheng Li Ke Xue Jin Zhan; 2007 Jan; 38(1):19-24. PubMed ID: 17438948
[TBL] [Abstract][Full Text] [Related]
11. Protease-activated receptor-2 (PAR2) in cardiovascular system.
Bucci M; Roviezzo F; Cirino G
Vascul Pharmacol; 2005 Oct; 43(4):247-53. PubMed ID: 16183333
[TBL] [Abstract][Full Text] [Related]
12. [Natriuretic peptides--their receptors and role in cardiovascular system].
Jerczyńska H; Pawłowska Z
Postepy Biochem; 2008; 54(1):35-42. PubMed ID: 18610580
[TBL] [Abstract][Full Text] [Related]
13. Rho exchange factors in the cardiovascular system.
Loirand G; Scalbert E; Bril A; Pacaud P
Curr Opin Pharmacol; 2008 Apr; 8(2):174-80. PubMed ID: 18222728
[TBL] [Abstract][Full Text] [Related]
14. Abundance of intrinsic disorder in protein associated with cardiovascular disease.
Cheng Y; LeGall T; Oldfield CJ; Dunker AK; Uversky VN
Biochemistry; 2006 Sep; 45(35):10448-60. PubMed ID: 16939197
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic proteins and growth differentiation factors as drug targets in cardiovascular and metabolic disease.
Tobin JF; Celeste AJ
Drug Discov Today; 2006 May; 11(9-10):405-11. PubMed ID: 16635802
[TBL] [Abstract][Full Text] [Related]
16. Bioorganic studies on marine natural products--diverse chemical structures and bioactivities.
Uemura D
Chem Rec; 2006; 6(5):235-48. PubMed ID: 17099881
[TBL] [Abstract][Full Text] [Related]
17. Natural products: chemical instruments to apprehend biological symphony.
Pucheault M
Org Biomol Chem; 2008 Feb; 6(3):424-32. PubMed ID: 18219406
[TBL] [Abstract][Full Text] [Related]
18. 'Relaxin' the stiffened heart and arteries: the therapeutic potential for relaxin in the treatment of cardiovascular disease.
Samuel CS; Du XJ; Bathgate RA; Summers RJ
Pharmacol Ther; 2006 Nov; 112(2):529-52. PubMed ID: 16814863
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in the endothelin system: do polymorphisms affect the therapeutic strategies?
Rossi GP; Pitter G
Ann N Y Acad Sci; 2006 Jun; 1069():34-50. PubMed ID: 16855133
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptides in neurogenic disorders of the cardiovascular control.
Szczepańska-Sadowska E
J Physiol Pharmacol; 2006 Nov; 57 Suppl 11():31-53. PubMed ID: 17244937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
